Showing 36,902 results

Filters
Hepatitis B

Hepatitis B Reactivation Risk Low in People With HIV Following Antiretroviral Switch

Editor's pick
Contagion Live
17 October 2023
People with limited treatment options

Intramuscular Administration of HIV Treatment Ibalizumab Compared With IV Infusion

Editor's pick
Monthly Prescribing Reference
17 October 2023
HIV treatment

Real-World Evidence Reinforces Biktarvy® as a Long-Term Treatment Option With a High Barrier to Resistance for People With HIV and a Range of Comorbidities

Editor's pick
Gilead Sciences press release
19 October 2023
Exposure to HIV through medical procedures

‘I stopped counting how many friends died’: life after the contaminated blood scandal

Editor's pick
The Guardian
19 October 2023
People with limited treatment options

Sunlenca Remains Active Against Drug-Resistant HIV

Editor's pick
POZ
19 October 2023
Bad science & bogus treatments

Beware of this dangerous advice! Colloidal silver cannot be used as an antibiotic or HIV medication

Editor's pick
Africa Check
19 October 2023
Injectable & long-acting PrEP

Gilead Sciences Announces New Clinical Trial in Europe to Assess Lenacapavir for HIV Prevention as Part of Landmark Purpose Program

Editor's pick
Gilead Sciences press release
19 October 2023
Improving HIV care

Pharmacist-Driven ART Start Cuts 37 Day Off Time From HIV Diagnosis to Undetectable

Editor's pick
NATAP
19 October 2023
Weight gain & lipodystrophy

Weight Loss or Gain Predictors Hard to Find in INSTI-to-PI Switch Trial

Editor's pick
NATAP
19 October 2023
Injectable & long-acting PrEP

Community Manifesto for HIV Long-Acting Injectable PrEP in Europe

Editor's pick
EATG
20 October 2023
Economic & social inequality

10 Charged in $20 Million Scheme to Sell Black-Market HIV Drugs

Editor's pick
The New York Times
23 October 2023
Human rights

UK Government commits to equal fertility rights for people living with HIV

Editor's pick
National AIDS Trust
24 October 2023
Mental & emotional health & wellbeing

PrEP Adherence and Depression Screening in LGBTQ+ Communities

Editor's pick
Infectious Disease Advisor
24 October 2023
Global health initiatives

George W. Bush steps up campaign to renew his AIDS-fighting program

Editor's pick
Politico
25 October 2023
People & personal stories

From HIV to obesity – Professor Francois Venter on fighting for better health for more people

Editor's pick
Daily Maverick
25 October 2023
PrEP programmes & uptake

Over a million South Africans have used the HIV prevention pill

Editor's pick
Bhekisisa
25 October 2023
Discrimination & the law

Tennessee faces federal lawsuit over decades-old penalties targeting HIV-positive people

Editor's pick
NBC News
25 October 2023
Activism & civil society

What’s Lost When an AIDS Walk Becomes a Health Equity Walk?

Editor's pick
POZ
25 October 2023
TB transmission & prevention

Tuberculosis vaccine breakthrough is a significant step forward

Editor's pick
Be In The Know
25 October 2023
Support issues for children & young people

HIV-positive parents in Zimbabwe struggle to manage their children's education – study shows how

Editor's pick
The Conversation
25 October 2023
Injectable & long-acting HIV treatment

ViiV Healthcare receives approval from China’s national medical products administration for Vocabria (cabotegravir) used in combination with Rekambys (rilpivirine)

Editor's pick
ViiV press release
26 October 2023
Finding support

Poz Nights at Gay Bars Were Wonderful — And Now Outdated

Editor's pick
HIVPlusMag.com
26 October 2023
Injectable & long-acting HIV treatment

Cabotegravir/Rilpivirine Injections Administered During Home Health Visit Show Promise in Pilot Study

Editor's pick
TheBodyPro
26 October 2023
Bone & joint problems

Classic Fracture Risk Factors May Need Replacing in Older People With HIV

Editor's pick
NATAP
27 October 2023